Hyperbaric Medicine in Pediatrics - reality of a Portuguese reference center

Catarina Freitas1, Luís Salazar2, Sílvia Duarte-Costa1

  • 1Unidade Local de Saúde de Matosinhos - Porto, Portugal.

Insights

Pediatric hyperbaric oxygen therapy is safe and effective, primarily for carbon monoxide poisoning and sudden hearing loss. This study highlights the benefits and need for wider pediatrician awareness of this crucial treatment.

Area of Science:

  • Pediatric Medicine
  • Hyperbaric Medicine
  • Emergency Medicine

Background:

  • Hyperbaric oxygen therapy (HBOT) offers therapeutic benefits for various conditions.
  • Pediatric HBOT utilization data is limited, particularly in Portugal.
  • Understanding referral patterns is crucial for optimizing resource allocation.

Purpose of the Study:

  • To characterize the pediatric patient population referred for hyperbaric oxygen therapy.
  • To identify common indications and outcomes of HBOT in children.
  • To assess the safety and efficacy of HBOT in a pediatric cohort.

Main Methods:

  • Retrospective, observational study of pediatric patients (2006-2021).
  • Data collected from electronic medical records at a reference hyperbaric center in Northern Portugal.
  • Analysis of referral reasons, treatment context, symptoms, and adverse effects.

Main Results:

  • 134 pediatric patients were included.
  • Most frequent referrals: carbon monoxide poisoning (n=59) and sudden sensorineural hearing loss (n=41).
  • Urgent treatment initiated in 56% of cases; favorable outcomes with minimal adverse events (oxygen toxicity, barotrauma).

Conclusions:

  • Carbon monoxide poisoning is the leading indication for pediatric HBOT.
  • HBOT demonstrates a favorable safety profile in children.
  • Increased pediatrician awareness of HBOT benefits is essential for broader implementation.
Abstract